H19 and TUG1 lncRNAs as Novel Biomarkers for Irritable Bowel Syndrome in Diabetic Patients.

Marwa M EsawyNoorah Saleh Al-Sowayan Maysa A MobasherAmir Abd-ElhameedElsayed S Abd Elbaser Shereen A BaioumyMarwa A Shabana

Published in: Biomedicines (2022)

Diabetic patients with IBS had significantly lower levels of lncRNA H19 and TUG1 expression than healthy controls and diabetic-only patients. LncRNA H19 had better diagnostic performance criteria for IBS. LncRNA H19 expression can be an independent predictor for IBS severity.

Keyphrases

irritable bowel syndrome
poor prognosis
long non coding rna
end stage renal disease
type diabetes
chronic kidney disease
ejection fraction
newly diagnosed
long noncoding rna
wound healing
binding protein
prognostic factors
patient reported